These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35389604)

  • 21. Medical consequences of acromegaly: what are the effects of biochemical control?
    Colao A; Auriemma RS; Pivonello R; Galdiero M; Lombardi G
    Rev Endocr Metab Disord; 2008 Mar; 9(1):21-31. PubMed ID: 18163212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.
    Sharma AN; Tan M; Amsterdam EA; Singh GD
    Clin Cardiol; 2018 Mar; 41(3):419-425. PubMed ID: 29574794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acromegalic cardiomyopathy].
    Bencze A; Rácz K
    Orv Hetil; 2011 Nov; 152(47):1875-8. PubMed ID: 22042313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly.
    Powlson AS; Gurnell M
    Neuroendocrinology; 2016; 103(1):75-85. PubMed ID: 26227953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell death in acromegalic cardiomyopathy.
    Frustaci A; Chimenti C; Setoguchi M; Guerra S; Corsello S; Crea F; Leri A; Kajstura J; Anversa P; Maseri A
    Circulation; 1999 Mar; 99(11):1426-34. PubMed ID: 10086965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.
    Wijayaratne DR; Arambewela MH; Dalugama C; Wijesundera D; Somasundaram N; Katulanda P
    J Med Case Rep; 2015 Oct; 9():241. PubMed ID: 26514337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
    Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
    Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acromegaly in the elderly patients.
    Ambrosio MR; Gagliardi I; Chiloiro S; Ferreira AG; Bondanelli M; Giampietro A; Bianchi A; Marinis L; Fleseriu M; Zatelli MC
    Endocrine; 2020 Apr; 68(1):16-31. PubMed ID: 32060689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acromegaly and Heart Failure.
    Colao A; Grasso LFS; Di Somma C; Pivonello R
    Heart Fail Clin; 2019 Jul; 15(3):399-408. PubMed ID: 31079698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CARDIOVASCULAR COMPLICATIONS OF ACROMEGALY.
    Mizera Ł; Elbaum M; Daroszewski J; Bolanowski M
    Acta Endocrinol (Buchar); 2018; 14(3):365-374. PubMed ID: 31149285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acromegaly, inflammation and cardiovascular disease: a review.
    Wolters TLC; Netea MG; Riksen NP; Hermus ARMM; Netea-Maier RT
    Rev Endocr Metab Disord; 2020 Dec; 21(4):547-568. PubMed ID: 32458292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acromegaly with Normal Insulin-Like Growth Factor-1 Levels and Congestive Heart Failure as the First Clinical Manifestation.
    Lee HM; Lee SH; Yang IH; Hwang IK; Hwang YC; Ahn KJ; Chung HY; Hwang HJ; Jeong IK
    Endocrinol Metab (Seoul); 2015 Sep; 30(3):395-401. PubMed ID: 25491785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of patients with acromegaly and congestive heart failure.
    Bihan H; Espinosa C; Valdes-Socin H; Salenave S; Young J; Levasseur S; Assayag P; Beckers A; Chanson P
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5308-13. PubMed ID: 15531475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone secreting pituitary carcinomas: Case report and review of literature.
    Vekaria S; Chen F; Zan E; William C; Sen C; Lebowitz R; Zagzag D; Warren FA; Brandler TC; Agrawal N
    Growth Horm IGF Res; 2021; 60-61():101430. PubMed ID: 34607164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased circulating levels of irisin are associated with cardiovascular risk factors in subjects with acromegaly.
    Calan M; Demirpence M
    Hormones (Athens); 2019 Dec; 18(4):435-442. PubMed ID: 31696447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.